Definitive Contract HHSD200201692407C

Award Date 9/27/16
Potential Completion Date 3/26/22
Potential Value $42M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Croatia
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
13
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded a $4,737,892.04 firm fixed-price definitive contract to Fresenius Kabi, LLC, a foreign-owned for-profit pharmaceutical company, to provide bulk pharmaceutical drugs. The contract has a completion date of February 29, 2024 and does not include a set-aside designation. Fresenius Kabi will manufacture and deliver a variety of generic injectable drugs and solutions, such as pain...
This is a federal contract award from the Centers for Disease Control and Prevention (CDC) to Fresenius Kabi USA, LLC, a foreign-owned, for-profit pharmaceutical company. The contract, a delivery order valued at $10,062,096.00, is for the provision of injectable drugs, intravenous solutions, and other pharmaceutical products. The contract is a firm-fixed-price arrangement and does not have a set-aside designation, reflecting Fresenius Kabi USA, LLC's status as a large, foreign-owned business...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Fresenius Kabi USA, LLC, a foreign-owned pharmaceutical company. The $443,723.27 contract is for the delivery of injectable drugs, intravenous solutions, and other pharmaceutical products. This order was issued against the Pharmaceuticals and Drugs Federal Supply Schedule, a government-wide acquisition vehicle managed by the Department of Veterans Affairs. The contract does...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company based in Lake Zurich, Illinois. The $971,596.05 firm fixed-price delivery order is for the supply of various injectable medications, including pain relievers, anesthetics, diuretics, and other critical care pharmaceuticals, to support military healthcare operations. Fresenius Kabi is a major provider of generic injectable...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company based in Lake Zurich, Illinois. The contract, valued at $9,692.20, is a delivery order for the supply of 4,566,185,312 units of Vancomycin 1 gram vials. The contract has an ultimate completion date of October 28, 2024, and is a firm fixed-price contract. Fresenius Kabi, LLC is a significant supplier of critical care...
This federal contract award, valued at $1,778.20, was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company based in Lake Zurich, Illinois. The contract is for the delivery of calcium gluconate injection, a critical care pharmaceutical product, with a completion date of November 22, 2024. Fresenius Kabi is a significant supplier of injectable medications and medical solutions to federal government...
This is a delivery order contract awarded to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company, by the Defense Logistics Agency (DLA) Troop Support Medical division. The contract, valued at $42,434.98, is for the delivery of Vancomycin 1 gram vials to federal government agencies. The contract is a firm fixed-price delivery order with an ultimate completion date of October 28, 2024. Fresenius Kabi is a significant supplier of critical care pharmaceuticals, focusing primarily...
This federal contract award, valued at $8,517.82, was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company based in Lake Zurich, Illinois. The contract is for the delivery of Doxycycline Hydrochloride Injection, a critical care pharmaceutical product, with a completion date of September 27, 2024. This is a firm fixed-price delivery order contract with no set-aside designation. Fresenius Kabi, LLC is...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency Troop Support Medical (DLA Troop Support Medical) to Fresenius Kabi USA, LLC, a foreign-owned, for-profit pharmaceutical company. The $77,398.92 award is for the delivery of 1 gram vials of vancomycin hydrochloride, a critical antibiotic used in the federal government's medical supply chain. This order was issued against the Pharmaceuticals and Drugs Federal Supply Schedule, a government-wide acquisition vehicle...
This federal contract award, SPE2D020D0009|SPE2D325F6852, was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company based in Lake Zurich, Illinois. The $3,632.58 firm fixed-price delivery order is for the supply of Calcium Gluconate Injection USP 100mg/mL 10mL, a critical care pharmaceutical. This order is not associated with a set-aside program. Fresenius Kabi, LLC holds a significant Indefinite Delivery...

This is a definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency, to Fresenius Kabi, LLC, a foreign-owned for-profit pharmaceutical company. The contract, valued at $41,636,277.00, is for the delivery of pharmaceutical and medical supplies, with no set-aside designation. The contract is structured as a firm fixed-price, delivery order arrangement to support medical facilities worldwide, particularly for the Department of Defense and Department of Veterans Affairs. Fresenius Kabi, LLC is a major supplier of critical care injectable medications to federal agencies, holding a significant indefinite delivery contract with the Department of Veterans Affairs National Acquisition Center for the cancer treatment drug bortezomib.

Generated 4/2/25, 8:06 PM